All you need to know about Russia's Sputnik V coronavirus vaccine which is easier to store

In a statement on Tuesday, the vaccine's developers said preliminary data after trials involving thousands of volunteers showed "an efficacy of the vaccine above 95 percent" after a second dose.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news